Cargando…
Polyclonal T-Cells Express CD1a in Langerhans Cell Histiocytosis (LCH) Lesions
Langerhans cell histiocytosis (LCH) is a complex and poorly understood disorder that has characteristics of both inflammatory and neoplastic disease. By using eight-colour flow cytometry, we have identified a previously unreported population of CD1a(+)/CD3(+) T-cells in LCH lesions. The expression o...
Autores principales: | West, Jennifer A., Olsen, Sharon L., Mitchell, Jenée M., Priddle, Ross E., Luke, Jennifer M., Åkefeldt, Selma Olsson, Henter, Jan-Inge, Turville, Christopher, Kannourakis, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208746/ https://www.ncbi.nlm.nih.gov/pubmed/25343480 http://dx.doi.org/10.1371/journal.pone.0109586 |
Ejemplares similares
-
Plasma Signaling Factors in Patients With Langerhans Cell Histiocytosis (LCH) Correlate With Relative Frequencies of LCH Cells and T Cells Within Lesions
por: Mitchell, Jenée, et al.
Publicado: (2022) -
Altered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell Histiocytosis
por: Mitchell, Jenée, et al.
Publicado: (2018) -
Hepatic Langerhans Cell Histiocytosis (LCH) Presenting as a Harbinger of Multisystem LCH
por: Li, Hua, et al.
Publicado: (2020) -
Patients with both Langerhans cell histiocytosis and Crohn’s disease highlight a common role of interleukin‐23
por: Kvedaraite, Egle, et al.
Publicado: (2020) -
Langerhans cell histiocytosis: A malignant myeloid neoplasm or disorder of immune regulation?
por: Mitchell, Jenee, et al.
Publicado: (2021)